{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-025001","form_type":"8-K","ticker":null,"cik":"0001450416","company_name":"LexaGene Holdings Inc.","filed_at":"2023-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.055410+00:00","generated_at":"2026-06-19T00:39:13.440478+00:00","sec_items":["1.03","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"LexaGene files for Chapter 7 bankruptcy, ceases operations and lays off staff","bullets":["Filed voluntary Chapter 7 petition in U.S. Bankruptcy Court for District of Massachusetts on Feb 24, 2023.","Company ceased operations and laid off all staff; federal trustee will liquidate assets.","CEO cites inability to secure funding, market conditions, and slow biopharma sales cycle.","No liquidation proceeds expected to satisfy all creditors; shareholders unlikely to receive any distribution.","Subsidiaries LexaGene, Inc. and Bionomics Diagnostics, Inc. included in filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-025001","json":"https://secwatch.observer/filing/0001104659-23-025001.json","markdown":"https://secwatch.observer/filing/0001104659-23-025001.md","text":"https://secwatch.observer/filing/0001104659-23-025001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1450416/000110465923025001/0001104659-23-025001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1450416/000110465923025001/tm237766d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T00:39:13.440478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7060d4a10fdb9ca42367c0e0120a2892b72e1f2f","claim":"LexaGene Holdings Inc. entered chapter 7 in United States Bankruptcy Court for the District of Massachusetts (petition 2023-02-24).","evidence_excerpt":"On February 24, 2023, LexaGene Holdings Inc. (the “ Company ”) filed for liquidation under Chapter 7 of Title 11 of the United States Code (the “ Bankruptcy Code ”) in the United States Bankruptcy Court for the District of Massachusetts (the “ Bankruptcy Court ”), located in Boston, Massachusetts.","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1450416/000110465923025001/0001104659-23-025001-index.htm","confidence":0.95,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 7"},{"label":"Court","value":"United States Bankruptcy Court for the District of Massachusetts"},{"label":"Petition","value":"2023-02-24"}],"fact_type":"distress_event"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}